Essential updates 2019/2020: Perioperative and surgical management of gastric cancer

被引：27

作者：

Irino, Tomoyuki ^{[1
]}

Matsuda, Satoru ^{[1
]}

Wada, Norihito ^{[1
]}

Kawakubo, Hirofumi ^{[1
]}

Kitagawa, Yuko ^{[1
]}

机构：

[1] Keio Univ, Sch Med, Dept Surg, Tokyo, Japan

来源：

ANNALS OF GASTROENTEROLOGICAL SURGERY | 2021年 / 5卷 / 02期

关键词：

adjuvant treatment; cancer of the gastroesophageal junction; gastric cancer; minimally invasive surgery; neoadjuvant treatment; precision medicine; DISTAL GASTRECTOMY; NEOADJUVANT CHEMOTHERAPY; PERITONEAL-LAVAGE; PHASE-III; MULTICENTER; TRIAL; EPIDEMIOLOGY; OXALIPLATIN; SURVIVAL; OUTCOMES;

D O I：

10.1002/ags3.12438

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Perioperative and surgical management of gastric cancer have been changing as pivotal phase II trials and landmark phase III trials offer new insights to the existing knowledge. The results of many landmark trials have been published or presented in the past year, many of which have changed or will change current clinical practice. For example, FLOT4 has completely changed the regimen of perioperative chemotherapy in Europe. Furthermore, evidence for minimally invasive surgery for clinical Stage I was firmly established by KLASS-01 and JCOG0912 for distal gastrectomy and CLASS-02, KLASS-03, and JCOG1401 for total gastrectomy. Moreover, promising results were provided by CLASS-01 and KLASS-02 for locally advanced gastric cancer. For adjuvant chemotherapy, JACCRO GC-07 (START-2) has provided a new doublet regimen for pathological Stage III, which is often refractory to chemotherapy. Conversely, JCOG0501 poses a significant challenge for advanced tumors, such as large type 3 and scirrhous (type 4) tumors. In this review, we briefly review recent updates and discuss future perspectives of gastric cancer treatment.

引用

页码：162 / 172

页数：11

共 74 条

[1] Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial [J].

Al-Batran, Salah-Eddin ;

Homann, Nils ;

Pauligk, Claudia ;

Goetze, Thorsten O. ;

Meiler, Johannes ;

Kasper, Stefan ;

Kopp, Hans-Georg ;

Mayer, Frank ;

Haag, Georg Martin ;

Luley, Kim ;

Lindig, Udo ;

Schmiegel, Wolff ;

Pohl, Michael ;

Stoehlmacher, Jan ;

Folprecht, Gunnar ;

Probst, Stephan ;

Prasnikar, Nicole ;

Fischbach, Wolfgang ;

Mahlberg, Rolf ;

Trojan, Joerg ;

Koenigsmann, Michael ;

Martens, Uwe M. ;

Thuss-Patience, Peter ;

Egger, Matthias ;

Block, Andreas ;

Heinemann, Volker ;

Illerhaus, Gerald ;

Moehler, Markus ;

Schenk, Michael ;

Kullmann, Frank ;

Behringer, Dirk M. ;

Heike, Michael ;

Pink, Daniel ;

Teschendorf, Christian ;

Loehr, Carmen ;

Bernhard, Helga ;

Schuch, Gunter ;

Rethwisch, Volker ;

von Weikersthal, Ludwig Fischer ;

Hartmann, Joerg T. ;

Kneba, Michael ;

Daum, Severin ;

Schulmann, Karsten ;

Weniger, Joerg ;

Belle, Sebastian ;

Gaiser, Timo ;

Oduncu, Fuat S. ;

Guentner, Martina ;

Hozaeel, Wael ;

Reichart, Alexander .

LANCET, 2019, 393 (10184) :1948-1957

[2] The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI [J].

Al-Batran, Salah-Eddin ;

Goetze, Thorsten O. ;

Mueller, Daniel W. ;

Vogel, Arndt ;

Winkler, Michael ;

Lorenzen, Sylvie ;

Novotny, Alexander ;

Pauligk, Claudia ;

Homann, Nils ;

Jungbluth, Thomas ;

Reissfelder, Christoph ;

Caca, Karel ;

Retter, Steffen ;

Horndasch, Eva ;

Gumpp, Julia ;

Bolling, Claus ;

Fuchs, Karl-Hermann ;

Blau, Wolfgang ;

Padberg, Winfried ;

Pohl, Michael ;

Wunsch, Andreas ;

Michl, Patrick ;

Mannes, Frank ;

Schwarzbach, Matthias ;

Schmalenberg, Harald ;

Hohaus, Michael ;

Scholz, Christian ;

Benckert, Christoph ;

Knorrenschild, Jorge Riera ;

Kanngiesser, Veit ;

Zander, Thomas ;

Alakus, Hakan ;

Hofheinz, Ralf-Dieter ;

Roedel, Claus ;

Shah, Manish A. ;

Sasako, Mitsuru ;

Lorenz, Dietmar ;

Izbicki, Jakob ;

Bechstein, Wolf O. ;

Lang, Hauke ;

Moenig, Stefan P. .

BMC CANCER, 2017, 17

[3] Laparoscopic sentinel node navigation surgery versus laparoscopic gastrectomy with lymph node dissection for early gastric cancer: short-term outcomes of a multicentre randomized controlled trial (SENORITA) [J].

An, J. Y. ;

Min, J-S ;

Hur, H. ;

Lee, Y. J. ;

Cho, G. S. ;

Park, Y-K ;

Jung, M. R. ;

Park, J-H ;

Hyung, W. J. ;

Jeong, S-H ;

Kim, Y-W ;

Yoon, H. M. ;

Eom, B. W. ;

Kook, M-C ;

Han, M. R. ;

Name, B-H ;

Ryu, K. W. .

BJS-BRITISH JOURNAL OF SURGERY, 2020, 107 (11) :1429-1438

[4] KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer [J].

Bang, Yung-Jue ;

Van Cutsem, Eric ;

Fuchs, Charles S. ;

Ohtsu, Atsushi ;

Tabernero, Josep ;

Ilson, David H. ;

Hyung, Woo Jin ;

Strong, Vivian E. ;

Goetze, Thorsten Oliver ;

Yoshikawa, Takaki ;

Tang, Laura H. ;

Hwang, Peggy May Tan ;

Webb, Nancy ;

Adelberg, David ;

Shitara, Kohei .

FUTURE ONCOLOGY, 2019, 15 (09) :943-952

[5] Incidence of gastroesophageal junction cancer continues to rise: Analysis of Surveillance, Epidemiology, and End Results (SEER) database. [J].

Bartel, Michael ;

Brahmbhatt, Bhaumik ;

Bhurwal, Abhishek .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)

[6] The Cholegas trial: long-term results of prophylactic cholecystectomy during gastrectomy for cancera randomized-controlled trial [J].

Bencini, Lapo ;

Marchet, Alberto ;

Alfieri, Sergio ;

Rosa, Fausto ;

Verlato, Giuseppe ;

Marrelli, Daniele ;

Roviello, Franco ;

Pacelli, Fabio ;

Cristadoro, Luigi ;

Taddei, Antonio ;

Farsi, Marco ;

Bernini, Marco ;

Gerard, Leonardo ;

Moretti, Renato ;

Cozzaglio, Luca ;

Berardi, Stefano ;

Bechi, Paolo .

GASTRIC CANCER, 2019, 22 (03) :632-639

[7]

Boku N., ANN ONCOL

[8] Epidemiology and Risk Factors for Gastroesophageal Junction Tumors: Understanding the Rising Incidence of This Disease [J].

Buas, Matthew F. ;

Vaughan, Thomas L. .

SEMINARS IN RADIATION ONCOLOGY, 2013, 23 (01) :3-9

[9] Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial [J].

Cats, Annemieke ;

Jansen, Edwin P. M. ;

van Grieken, Nicole C. T. ;

Sikorska, Karolina ;

Lind, Pehr ;

Nordsmark, Marianne ;

Kranenbarg, Elma Meershoek-Klein ;

Boot, Henk ;

Trip, Anouk K. ;

Swellengrebel, H. A. Maurits ;

van Laarhoven, Hanneke W. M. ;

Putter, Hein ;

van Sandick, Johanna W. ;

Henegouwen, Mark I. van Berge ;

Hartgrink, Henk H. ;

van Tinteren, Harm ;

van de Velde, Cornelis J. H. ;

Verheij, Marcel .

LANCET ONCOLOGY, 2018, 19 (05) :616-628

[10] Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis [J].

Cheong, Jae-Ho ;

Yang, Han-Kwang ;

Kim, Hyunki ;

Kim, Woo Ho ;

Kim, Young-Woo ;

Kook, Myeong-Cherl ;

Park, Young-Kyu ;

Kim, Hyung-Ho ;

Lee, Hye Seung ;

Lee, Kyung Hee ;

Gu, Mi Jin ;

Kim, Ha Yan ;

Lee, Jinae ;

Choi, Seung Ho ;

Hong, Soonwon ;

Kim, Jong Won ;

Choi, Yoon Young ;

Hyung, Woo Jin ;

Jang, Eunji ;

Kim, Hyeseon ;

Huh, Yong-Min ;

Noh, Sung Hoon .

LANCET ONCOLOGY, 2018, 19 (05) :629-638

← 1 2 3 4 5 6 7 8 →